Delivery Order SPE2DB22D1017-SPE2DB24FF0FF
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 270 units of ESBRIET 267 MG CAPSULE. The award, valued at $3,311.50, has a completion date of February 8, 2024. AmerisourceBergen Drug Corp, a for-profit organization, provides pharmaceutical products and services to U.S. government agencies, primarily the Department of Defense. The company has received numerous federal contract...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $3,311.50 order is for the supply of ESBRIET 801 MG TABLETS 90S, a pharmaceutical product, with a completion date of January 19, 2024. The contract has no set-aside designation. Amerisourcebergen Drug Corp has previously received multiple pharmaceutical and medical supply delivery orders...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $3,311.50 firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to supply 4562926660 ESBRIET 267 MG CAPSULE 270S. The order was awarded on November 28, 2023 under the company's indefinite delivery contract with no set-aside designation specified. Performance will occur at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania with completion by December 19, 2023....
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution services company. The $3,311.50 contract is for the provision of ESBRIET 267 MG CAPSULE 270S and has a completion date of March 26, 2024. Amerisourcebergen Drug Corp, located in Conshohocken, Pennsylvania, is the prime contractor on this award, which is not designated as a set-aside....
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order worth $3,311.50 by the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the delivery of ESBRIET 267 MG CAPSULE 270S, a pharmaceutical product, with a completion date of March 26, 2024. This delivery order is part of Amerisourcebergen Drug Corp's broader indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 and running through...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $3,311.50 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) for the supply of ESBRIET 801 MG TABLET 90S. This contract has a completion date of March 26, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing pharmaceutical products and medical supplies to U.S. government agencies, particularly the Department of Defense, through various indefinite delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a $3,311.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide ESBRIET 801 MG TABLET 90S. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ESBRIET 801 MG TABLET 90S. The total potential value of the order is $3,311.50, and the period of performance runs through January 12, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, is a prime contractor that has received numerous federal contract awards to supply pharmaceuticals, medical supplies,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $133,020.00 firm fixed price delivery order is for the supply of 4558537918 ESBRIET 267 MG CAPSULE 270S, a pharmaceutical product, to support DLA Troop Support Medical facilities. The contract has a completion date of October 13, 2022 and was awarded on September 21, 2022....
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,867,993 ESBRIET 267 MG CAPSULE 270S for a total potential value of $3,311.50. This delivery order has a completion date of March 26, 2024 and was awarded on March 5, 2024. Amerisourcebergen Drug Corp is the prime contractor and is a for-profit organization headquartered in Conshohocken,...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF0FFDelivery Order
The U.S. Defense Logistics Agency awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 270 units of the pharmaceutical product ESBRIET 267 MG CAPSULE. The $3,311.50 order has a completion date of January 17, 2024 and was awarded on December 22, 2023. Amerisourcebergen Drug Corp is an experienced federal contractor that has provided a variety of pharmaceutical and medical supplies to the Defense Logistics Agency and other government agencies, including the Department of Justice Federal Bureau of Investigation. This delivery order is part of Amerisourcebergen's existing indefinite delivery contract vehicle with the DLA to support military treatment programs and facilities. No set-aside designation was used for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 12/22/23 |